PrabotulinumtoxinA (Jeuveau) for Frown Lines

Date: May 20, 2019
Issue #: 
1572Summary: 
The FDA has approved prabotulinumtoxinA-xvfs
(Jeuveau– Evolus) for temporary improvement in
the appearance of moderate to severe glabellar lines
associated with corrugator and/or procerus muscle
activity.Jeuveau is the fourth botulinum toxin
product to be approved in the US for this indication
(see Table 1). It has been available in South Korea asNabota since 2014.

Source: The Medical Letter - March 20, 2019 Category: Drugs & Pharmacology Authors: admin Tags: Botox Botulinum toxin Dysport Jeuveau Nuceiva Xeomin Source Type: research